ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

No reported Retained Earnings figures are available to summarize.

Retained Earnings history

Currency unavailable · from the balance sheet

No Retained Earnings data reported for this period type.

Retained Earnings vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Retained Earnings for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
RNAAtrium Therapeutics, Inc.Mar 2026$12.13M USD——4.1%
BNTCBenitec Biopharma Inc.Mar 2026-$260.91M USD-23.1%—139.5%
PRQRProQR Therapeutics N.V.Mar 2026-€479.39M EUR-1.7%—483.6%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026-$541.55M USD-17.0%—220.7%
STOKStoke Therapeutics, Inc.Mar 2026-$547.72M USD-44.9%—123.6%
SLNSilence Therapeutics plcMar 2026-$577.53M USD-214.9%—501.7%
MGTXMeiraGTx Holdings plcMar 2026-$862.54M USD-16.2%—352.6%
PRMEPrime Medicine, Inc.Mar 2026-$937.48M USD-26.8%—318.1%
WVEWave Life Sciences Ltd.Mar 2026-$1.35B USD-15.7%—231.7%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-20.0%—231.7%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.